Zedira
Zedira is a clinical stage biopharmaceutical company and the global leader in Transglutaminase technology, offering >250 exclusive products accompanied by customized services. Scientists from academia and industry (including most of the top-15 pharmaceutical companies) rely on Zedira’s expertise and ISO9001:2015-certified production facility.
Zedira’s recombinant, ultra-pure, and highly active microbial transglutaminase (MTG, Andracon®) enables the generation of homogenous ADCs with defined drug-to-antibody ratios. Today, novel ADCs manufactured with Zedira’s MTG are entering clinical trials.
